Roles for Growth Factors in Cancer Progression

被引:358
作者
Witsch, Esther [1 ]
Sela, Michael [1 ]
Yarden, Yosef [2 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
[2] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
基金
以色列科学基金会;
关键词
HUMAN-BREAST-CANCER; SQUAMOUS-CELL CARCINOMA; COPY NUMBER CHANGES; I RECEPTOR GENE; TGF-BETA; TUMOR-GROWTH; MESENCHYMAL TRANSITION; MONOCLONAL-ANTIBODIES; NUCLEAR-LOCALIZATION; MALIGNANT GLIOMAS;
D O I
10.1152/physiol.00045.2009
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Under physiological conditions, cells receive fate-determining signals from their tissue surroundings, primarily in the form of polypeptide growth factors. Integration of these extracellular signals underlies tissue homeostasis. Although departure from homeostasis and tumor initiation are instigated by oncogenic mutations rather than by growth factors, the latter are the major regulators of all subsequent steps of tumor progression, namely clonal expansion, invasion across tissue barriers, angiogenesis, and colonization of distant niches. Here, we discuss the relevant growth factor families, their roles in tumor biology, as well as the respective downstream signaling pathways. Importantly, cancer-associated activating mutations that impinge on these pathways often relieve, in part, the reliance of tumors on growth factors. On the other hand, growth factors are frequently involved in evolvement of resistance to therapeutic regimens, which extends the roles for polypeptide factors to very late phases of tumor progression and offers opportunities for cancer therapy.
引用
收藏
页码:85 / 101
页数:17
相关论文
共 112 条
[1]   EFFICACY OF ANTIBODIES TO EPIDERMAL GROWTH-FACTOR RECEPTOR AGAINST KB CARCINOMA INVITRO AND IN NUDE-MICE [J].
ABOUDPIRAK, E ;
HURWITZ, E ;
PIRAK, ME ;
BELLOT, F ;
SCHLESSINGER, J ;
SELA, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (20) :1605-1611
[2]   THE INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR GENE IS THE TARGET FOR THE 15Q26 AMPLICON IN BREAST-CANCER [J].
ALMEIDA, A ;
MULERIS, M ;
DUTRILLAUX, B ;
MALFOY, B .
GENES CHROMOSOMES & CANCER, 1994, 11 (01) :63-65
[3]   ANTI-TRANSFORMING GROWTH-FACTOR (TGF)-BETA ANTIBODIES INHIBIT BREAST-CANCER CELL TUMORIGENICITY AND INCREASE MOUSE SPLEEN NATURAL-KILLER-CELL ACTIVITY - IMPLICATIONS FOR A POSSIBLE ROLE OF TUMOR-CELL HOST TGF-BETA INTERACTIONS IN HUMAN BREAST-CANCER PROGRESSION [J].
ARTEAGA, CL ;
HURD, SD ;
WINNIER, AR ;
JOHNSON, MD ;
FENDLY, BM ;
FORBES, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2569-2576
[4]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[5]  
Atlas E, 2003, MOL CANCER RES, V1, P165
[6]   Targeting tyrosine kinases in cancer: The second wave [J].
Baselga, Jose .
SCIENCE, 2006, 312 (5777) :1175-1178
[7]   Genetic progression and the waiting time to cancer [J].
Beerenwinkel, Niko ;
Antal, Tibor ;
Dingli, David ;
Traulsen, Arne ;
Kinzler, Kenneth W. ;
Velculescu, Victor E. ;
Vogelstein, Bert ;
Nowak, Martin A. .
PLOS COMPUTATIONAL BIOLOGY, 2007, 3 (11) :2239-2246
[8]   Cancer therapeutic antibodies come of age: Targeting minimal residual disease [J].
Ben-Kasus, Tsipi ;
Schechter, Bilha ;
Sela, Michael ;
Yarden, Yosef .
MOLECULAR ONCOLOGY, 2007, 1 (01) :42-54
[9]   Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: Relevance of receptor endocytosis [J].
Ben-Kasus, Tsipi ;
Schechter, Bilha ;
Lavi, Sara ;
Yarden, Yosef ;
Sela, Michael .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (09) :3294-3299
[10]   Transforming growth factor-β regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment [J].
Bierie, Brian ;
Stover, Daniel G. ;
Chytil, Anna ;
Gorska, Agnieszka E. ;
Aakre, Mary ;
Forrester, Elizabeth ;
Yang, Li ;
Wagner, Kay-Uwe ;
Moses, Harold L. .
CANCER RESEARCH, 2008, 68 (06) :1809-1819